Answers are grounded in this paper and cite their sources.
Clinical review describes tumor risk in abnormal sexual differentiation, indicating that specific genetic and histological patterns guide the timing of preventive gonadal surgery.
Clinical EndocrinologyVolume 32, Issue 4 p. 519-534 GONADAL NEOPLASIA AND ABNORMAL SEXUAL DIFFERENTIATION M. O. SAVAGE, M. O. SAVAGE Departments of Child Health, Endocrinology, and Histopathology, St Bartholomew's Hospital, London EC1A 7BE, UKSearch for more papers by this authorD. G. LOWE, D. G. LOWE Departments of Child Health, Endocrinology, and Histopathology, St Bartholomew's Hospital, London EC1A 7BE, UKSearch for more papers by this author M. O. SAVAGE, M. O. SAVAGE Departments of Child Health, Endocrinology, and Histopathology, St Bartholomew's Hospital, London EC1A 7BE, UKSearch for more papers by this authorD. G. LOWE, D. G. LOWE Departments of Child Health, Endocrinology, and Histopathology, St Bartholomew's Hospital, London EC1A 7BE, UKSearch for more papers by this author First published: April 1990 https://doi.org/10.1111/j.1365-2265.1990.tb00893.xCitations: 66AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.
No takes yet. Share an insight, caveat, or question.
Savage et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: